Topics

GTx Incorporated
SEC accuses doctors of insider trading after clinical trial halted
SEC accuses doctors of insider trading after clinical trial halted

Two San Bernardino doctors agreed to pay more than $100,000 in penalties for allegedly selling a pharmaceutical company’s stock after learning that regulators were halting a clinical trial of a prostate cancer drug they were testing.   The Securities and Exchange Commission accused Dr. Franklin Chu and Dr. Daniel Lama of insider trading after they avoided significant losses by selling shares of GTx Inc. before the Memphis company disclosed it had been ordered to stop testing the drug Capesaris. Chu and Lama, who practice at San Bernardino Urological Associates Medical Group, had been involved in a clinical trial of the drug, a role that enabled them to get advance word that...

Loading